US 7273851
Tri-peptide hepatitis C serine protease inhibitors
granted A61KA61K38/00
Quick answer
US patent 7273851 (Tri-peptide hepatitis C serine protease inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Sep 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Sep 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K38/00